The comparison between the MGUS and SM/MM groups (Figure 4; Table S1 in Supplementary Material) revealed that only four molecules were slightly but significantly higher in SM/MM patients: HGF, IL-11, SDF-1α, and RANTES. This evidence concerns the gene CXCL12 and Miyoshi myopathy.